Amalgamated Bank’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-29,087
Closed -$862K 2993
2023
Q4
$862K Sell
29,087
-1,989
-6% -$39.6K 0.01% 1226
2023
Q3
$493K Buy
31,076
+652
+2% +$10.8K ﹤0.01% 1423
2023
Q2
$574K Buy
30,424
+4,293
+16% +$50.7K ﹤0.01% 1374
2023
Q1
$100K Sell
26,131
-4,741
-15% -$20.2K ﹤0.01% 2060
2022
Q4
$153K Hold
30,872
﹤0.01% 1955
2022
Q3
$148K Buy
30,872
+271
+0.9% +$1.43K ﹤0.01% 1969
2022
Q2
$138K Buy
30,601
+2,189
+8% +$9.51K ﹤0.01% 2041
2022
Q1
$135K Sell
28,412
-2,297
-7% -$12.7K ﹤0.01% 2088
2021
Q4
$228K Sell
30,709
-305
-1% -$1.9K ﹤0.01% 1935
2021
Q3
$176K Sell
31,014
-1,554
-5% -$8.98K ﹤0.01% 2017
2021
Q2
$215K Buy
32,568
+12,260
+60% +$85.5K ﹤0.01% 2010
2021
Q1
$164K Sell
20,308
-479
-2% -$3.91K 0.01% 1519
2020
Q4
$134K Buy
20,787
+883
+4% +$5.15K 0.01% 1506
2020
Q3
$72K Sell
19,904
-289
-1% -$1.17K ﹤0.01% 1434
2020
Q2
$93K Sell
20,193
-4,113
-17% -$17.5K ﹤0.01% 1405
2020
Q1
$83K Buy
24,306
+349
+1% +$1.53K ﹤0.01% 1517
2019
Q4
$122K Buy
23,957
+249
+1% +$845 ﹤0.01% 1711
2019
Q3
$57K Sell
23,708
-217
-0.9% -$576 ﹤0.01% 1699
2019
Q2
$52K Buy
23,925
+1,537
+7% +$3.63K ﹤0.01% 1745
2019
Q1
$61K Buy
22,388
+756
+3% +$3.27K ﹤0.01% 1632
2018
Q4
$104K Buy
+21,632
New +$131K ﹤0.01% 1519
2018
Q3
Sell
-19,529
Closed -$190K 1647
2018
Q2
$190K Buy
19,529
+6,183
+46% +$65.2K ﹤0.01% 1586
2018
Q1
$140K Sell
13,346
-200
-1% -$1.98K ﹤0.01% 1506
2017
Q4
$87K Buy
13,546
+2,834
+26% +$17.5K ﹤0.01% 1582
2017
Q3
$82K Sell
10,712
-158
-1% -$1.05K ﹤0.01% 1524
2017
Q2
$77K Buy
10,870
+536
+5% +$2.45K ﹤0.01% 1527
2017
Q1
$40K Buy
10,334
+2
+0% +$6 ﹤0.01% 1479
2016
Q4
$21K Buy
+10,332
New +$20.7K ﹤0.01% 1507

Other funds holding IMGN

Amalgamated Bank's IMGN Position: Q1 2024 in Review

Amalgamated Bank sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 29,087 shares — an estimated $862K sold.

Amalgamated Bank first reported a position in IMGN in Q4 2016 and held it in 28 quarters. The position peaked at $862K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Amalgamated Bank reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Amalgamated Bank sold 29,087 Immunogen Inc shares in Q1 2024, an estimated $862K.
  • Amalgamated Bank first reported a position in Immunogen Inc in Q4 2016 and held it in 28 quarters.
  • Amalgamated Bank's Immunogen Inc position peaked at $862K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Amalgamated Bank's 13F filing for Q1 2024, filed 23 Apr 2024.